No Data
The new policy of prepayment of medical insurance fund has been released, and the pharmaceutical sector has ushered in a sharp rise. Experts believe it may be a way for medical institutions to release funding pressure.
On the 11th, the "Notice on Prepayment of Medical Insurance Fund" was issued, requiring the unified and improved basic medical insurance fund prepayment system at the national level. Experts believe that the prepayment system can effectively alleviate the problem of pharmaceutical industry debt, accelerate the turnover of funds for pharmaceutical companies. The medical sector showed a significant upward trend today, with listed companies attributing the rise to investor sentiment.
JBM's Subsidiaries to Sell 20% Stake in Chinese Medicine Subsidiary to Jacobson Pharma Unit
Multiple bullish factors boost pharmaceutical Hong Kong stocks. Institutions say they still face this risk in the short term.
①What are the policy measures to support the field of innovative drugs? ②What unfavorable effects on domestic pharmaceutical stocks might Trump's election bring about?
Jacobson Pharma's Strategic Share Transaction Unveiled
jacobson pharma (02633.HK) plans to acquire approximately 46.23 million Hong Kong dollars of shares in Li Zhongsheng Tang (Group), around 0.1 million shares.
Grondstream November 11th | Jacobson Pharma (02633.HK) and JBM Healthcare(02161.HK) announced that on November 11, 2024, JBM Healthcare's indirectly wholly-owned subsidiaries Po Chai Herbal and JBM Healthcare's indirectly wholly-owned subsidiaries PCHT (as the sellers) entered into a sales agreement with Ulferts' indirectly wholly-owned subsidiaries Jacobson Pharma( as the buyer). Pursuant to this, Po Chai Herbal and PCHT conditionally agreed to sell 56,500 shares and 44,000 shares of sales shares respectively, while Ulferts Pharmaceutical conditionally agreed
Jacobson Pharma (02633): Po Chai Herbal and PCHT enter into a purchase agreement with Ulferts Pharmaceuticals.
jacobson pharma (02633) and jbm healthcare (02161) have jointly announced that in November 2024...
Jacobson Pharma's (HKG:2633) Profits Appear To Have Quality IssuesNo Data
No Data
